Sign In

Laurel A. Habel, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3715 (phone)
laurel.habel@kp.org
Kaiser Permanente Researcher Profiles


 
Laurel Habel, PhD, has been a research scientist at the Kaiser Permanente Northern California Division of Research since 1996. Dr. Habel obtained her master’s in public health in epidemiology from the University of California, Los Angeles in 1980 and her doctorate in epidemiology from the University of Washington, Seattle in 1996. Dr. Habel’s research interests include the etiology and progression of cancer and precursor lesions for cancer; mammographic density and other biomarkers of disease risk or progression; and the association between use of medications and cancer risk. She is the principal investigator or site principal investigator on several federally-funded research projects. 

Current Position(s):

  • Research Scientist III, Division of Research, Kaiser Permanente Northern California
  • Consulting Professor in Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA

Section Affiliations:

Primary Research Interests:

  • Breast cancer etiology and progression
  • Etiology and progression of precursor lesions for cancer
  • Mammographic density and other biomarkers of disease risk or progression
  • Use of medication and cancer risk

    Adherence to Oral Chemotherapy among Patients with Solid Tumors

    Use of oral chemotherapy agents for the treatment of many solid tumors has been increasing. This project aims to examine the use of oral chemotherapy over the last 10 years, the proportion of patients who are adherent to their oral therapy, and the factors related to adherence.
    Investigator: Habel, Laurel
    Funder: Northern California Community Benefit Programs

    Pharmaceuticals and Cancer

    This study continues surveillance of more than 200 of the most commonly prescribed drugs for carcinogenicity, and examines selected drug-cancer associations of potential importance.
    Investigator: Habel, Laurel
    Funder: Kaiser Permanente Institutional Planned Giving

    Genome-wide Pleiotropy Scan across Multiple Cancers

    Understanding similarities among phenotypically distinct cancers could provide insight into biological basis of disease and suggest treatment overlap among patients with seemingly distinct cancers. We will evaluate this by undertaking a genome-wide association study (GWAS) across all major cancers types in the genotyped cohort of the Research Program on Genes, Environment and Health. Our aims are to: 1) Undertake an overall cancer GWAS across cancer sites to obtain a baseline estimate of the potential pleiotrophic association of genetic variants with multiple cancers. 2) Apply recently developed cross-site GWAS methods to search for potential associations across varying subgroups of cancers. 3) Extend the approach applied in Aim 2 to consider more complex sets of cancer subtypes. 4) The potential subgroups for consideration in the combined GWAS will be based on germline genetic information. We will develop novel approaches that cluster individuals with cancer into potential subgroups that reflect their genetic similarity.
    Investigator: Habel, Laurel
    Funder: National Cancer Institute

    A Biophysical Stromal Basis for Radiation Sensitivity in Ductal Carcinoma in situ

    We hypothesize that high tensile forces of activated stroma play a critical role in the survival and proliferation of cancerous epithelial cells through direct involvement of the YAP-TAZ and PI3-k pathways, and that disengaging pro-survival mechanosignaling emanating from the activated stroma is a promising approach to enhancing therapeutic efficacy. Our goals are to determine if tensile forces specifically regulate ionizing radiation (IR) therapy resistance by testing 1) whether the YAP-TAZ and PI3-k pathways are acting independently in IR-mediated cell death and proliferation; and 2) whether integrin mechanosignaling modifies this regulation. In addition, we have the unique opportunity to investigate whether stromal biophysical and morphological features are associated YAP-TAZ signaling and disease progression in clinical DCIS.
    Investigator: Habel, Laurel
    Funder: National Cancer Institute

    Mammographic Density and Prognosis among Breast Cancer Intrinsic Subtypes

    The primary goal of this study is to determine whether mammographic density at diagnosis of invasive breast cancer predicts risk of subsequent breast cancer events among patients participating in two large and well-characterized population-based cohorts (LACE and Pathways) within the Kaiser Permanente Northern California health plan membership. Breast cancers have already been classified into intrinsic subtypes using a 50-gene assay (PAM50 assay).
    Investigator: Habel, Laurel
    Funder: National Cancer Institute

    Genome-Wide Association Study of Mammographic Density

    Mammographic density (MD) is one of the strongest known risk factors for breast cancer. Our primary goal is to identify novel genes for MD by conducting a genome-wide association study (GWAS) in 30,000 Caucasian women participating in KPNC's Research Program on Genes, Environment and Health (RPGEH). We will obtain routine screening mammograms and assess breast density. RPGEH and KPNC databases will provide genome-wide marker data for over 650K SNPs as well as extensive epidemiologic and medical data, including BMI, lifestyle and reproductive factors, and use of prescription medications.
    Investigator: Habel, Laurel
    Funder: National Cancer Institute

    A Comparison of HER2 Positive and HER2 Negative Disease among a Large Population-Based Cohort of Breast Cancer Patients

    The aims of this study are to: 1) Estimate the age-specific incidence of HER2+ breast cancer in the Northern California Kaiser Permanente membership. 2) Among breast cancer patients diagnosed between 2000 and 2005, compare demographic (e.g., age, race) and tumor (e.g., ER, PR, size, grade, nodal status) characteristics for those with HER2 positive and HER2 negative disease. 3) Among a random selection of HER2+ patients, collect additional information on cormorbid conditions of importance for treatment with Herceptin and/or entry into adjuvant clinical trials. 4) Compare the characteristics of HER2+ patients in the KP membership to those of patients entered into the standard adjuvant chemotherapy/Herceptin trials and estimate the percent of KP patients with HER2+ disease that would have been eligible for either of these trials.
    Investigator: Habel, Laurel
    Funder: Genentech, Inc.

    Study of Womens Health Across the Nation (SWAN): UC Davis and Kaiser Permanente

    The objective of this project is to follow a large multi-ethnic sample of premenopausal women through the menopausal transition, in order to investigate the influence of biological and social and cultural factors on age at menopause, symptoms of menopause and change in disease risk factor status.
    Investigator: Habel, Laurel
    Funder: National Institute on Aging

    Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors

    Author(s): Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML

    J Natl Cancer Inst. 2016 Mar;108(3). Epub 2015-12-01.

    PubMed abstract

    Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer

    Author(s): Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA

    J Cancer Surviv. 2018 Oct 18.

    PubMed abstract

    Photosensitizing Antihypertensive Drug Use and Risk of Cutaneous Squamous Cell Carcinoma

    Author(s): Su KA; Habel LA; Achacoso NS; Friedman GD; Asgari MM

    Br J Dermatol. 2018 May 03.

    PubMed abstract

    A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus

    Author(s): Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA

    Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):525-530.

    PubMed abstract

    Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

    Author(s): Krieger N; Nabavi S; Waterman PD; Achacoso NS; Acton L; Schnitt SJ; Habel LA

    Cancer Causes Control. 2018 Feb 09.

    PubMed abstract

    Serum cholesterol trajectories in the 10 years prior to lymphoma diagnosis

    Author(s): Alford SH; Divine G; Chao C; Habel LA; Janakiraman N; Wang Y; Feigelson HS; Scholes D; Roblin D; Epstein MM; Engel L; Havstad S; Wells K; Yood MU; Fortuny J; Johnson CC; Cancer Research Network Lymphoma Study Group

    Cancer Causes Control. 2017 Nov 30.

    PubMed abstract

    Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives

    Author(s): Emerson MA; Banegas MP; Chawla N; Achacoso N; Alexeeff SE; Adams AS; Habel LA

    Cancer Res. 2017 Dec 01;77(23):6770-6776. Epub 2017-11-29.

    PubMed abstract

    Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery

    Author(s): Punglia RS; Jiang W; Lipsitz SR; Hughes ME; Schnitt SJ; Hassett MJ; Nekhlyudov L; Achacoso N; Edge S; Javid SH; Niland JC; Theriault RL; Wong YN; Habel LA

    Breast Cancer Res Treat. 2017 Oct 28.

    PubMed abstract

    Age at menarche and late adolescent adiposity associated with mammographic density on processed digital mammograms in 24,840 women

    Author(s): Alexeeff SE; Odo N; Lipson JA; Achacoso N; Rothstein JH; Yaffe MJ; Liang RY; Acton L; McGuire V; Whitmore AS; Rubin DL; Sieh W; Habel LA

    Cancer Epidemiol Biomarkers Prev. 2017 Jul 11.

    PubMed abstract

    Hydrochlorothiazide use is strongly associated with risk of lip cancer

    Author(s): Potteg�rd A; Hallas J; Olesen M; Svendsen MT; Habel LA; Friedman GD; Friis S

    J Intern Med. 2017 May 08.

    PubMed abstract

    Research Letter: Anticholinergic Drugs and the Gallbladder - A Neglected Effect?

    Author(s): Friedman GD; Achacoso N; Habel LA

    Perm J. 2017;21.

    PubMed abstract

    Statin use and risk of multiple myeloma: An analysis from the Cancer Research Network

    Author(s): Epstein MM; Divine G; Chao CR; Wells KE; Feigelson HS; Scholes D; Roblin D; Yood MU; Engel LS; Taylor A; Fortuny J; Habel LA; Johnson CC

    Int J Cancer. 2017 Apr 20.

    PubMed abstract

    Feasibility of collecting tumor samples of breast cancer patients diagnosed up to 50 years ago in the Child Health and Development Studies

    Author(s): Krigbaum NY; Rubin RA; Cirillo PM; Terry MB; Habel LA; Morris C; Cohn BA

    J Dev Orig Health Dis. 2017 Mar 06:1-6.

    PubMed abstract

    Effect of Race and Ethnicity on Antihypertensive Medication Utilization Among Women in the United States: Study of Women's Health Across the Nation (SWAN)

    Author(s): Jackson EA; Ruppert K; Derby CA; Lian Y; Neal-Perry G; Habel LA; Tepper PG; Harlow SD; Solomon DH

    J Am Heart Assoc. 2017 Feb 23;6(3). Epub 2017-02-23.

    PubMed abstract

    Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.

    Author(s): Hoffmann TJ; Passarelli MN; Graff RE; Emami NC; Sakoda LC; Jorgenson E; Habel LA; Shan J; Ranatunga DK; Quesenberry CP; Chao CR; Ghai NR; Aaronson D; Presti J; Nordström T; Wang Z; Berndt SI; Chanock SJ; Mosley JD; Klein RJ; Middha M; Lilja H; |Melander O; Kvale MN; Kwok PY; Schaefer C; Risch N; Van Den Eeden SK; Witte JS;

    ​Nat Commun. 2017 Jan 31;8:14248. doi: 10.1038/ncomms14248.

    PubMed abstract

    The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening

    Author(s): Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA

    J Prim Care Community Health. 2016 Oct 31.

    PubMed abstract

    Statins and Reduced Risk of Liver Cancer: Evidence for Confounding

    Author(s): Friedman GD; Achacoso N; Fireman B; Habel LA

    J Natl Cancer Inst. 2016 Oct;108(10). Epub 2016-07-05.

    PubMed abstract

    Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma

    Author(s): Potteg?rd A; Schmidt SA; Olesen AB; Achacoso N; Van Den Eeden SK; Hallas J; S?rensen HT; Friis S; Habel LA

    Br J Cancer. 2016 Aug 16.

    PubMed abstract

    Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early Stage Breast Cancer; The LACE and Pathways Studies

    Author(s): Jones LW; Kwan ML; Weltzien EK; Chandarlapaty S; Sternfeld B; Sweeney C; Bernard PS; Castillo AL; Habel LA; Kroenke CH; Langholz BM; Quesenberry CP; Dang CT; Weigelt B; Kushi LH; Caan BJ

    Cancer Res. 2016 Aug 3.

    PubMed abstract

    Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer

    Author(s): Jones LW; Habel LA; Weltzien E; Castillo A; Gupta D; Kroenke CH; Kwan ML; Quesenberry CP; Scott J; Sternfeld B; Yu A; Kushi LH; Caan BJ

    J Clin Oncol. 2016 May 23.

    PubMed abstract

    Case-control study of mammographic density and breast cancer risk using processed digital mammograms

    Author(s): Habel LA; Lipson JA; Achacoso N; Rothstein JH; Yaffe MJ; Liang RY; Acton L; McGuire V; Whittemore AS; Rubin DL; Sieh W

    Breast Cancer Res. 2016;18(1):53. Epub 2016-05-21.

    PubMed abstract

    Breast cancer multigene testing trends and impact on chemotherapy use

    Author(s): Ray GT; Mandelblatt J; Habel LA; Ramsey S; Kushi LH; Li Y; Lieu TA

    Am J Manag Care. 2016;22(5):e153-60. Epub 2016-05-01.

    PubMed abstract

    Time for integrating clinical, lifestyle and molecular data to predict drug responses - Authors' reply

    Author(s): Pottegård A; Friis S; Christensen Rd; Habel LA; Gagne JJ; Hallas J;

    EBioMedicine. 2016 May;7:11. Epub 2016-03-18.

    PubMed abstract

    Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study

    Author(s): Pottegård A; Friis S; Christensen Rd; Habel LA; Gagne JJ; Hallas J;

    EBioMedicine. 2016 May;7:73-9. Epub 2016-03-14.

    PubMed abstract

    Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors

    Author(s): Haque R; Shi J; Schottinger JE; Ahmed SA; Cheetham TC; Chung J; Avila C; Kleinman K; Habel LA; Fletcher SW; Kwan ML

    J Natl Cancer Inst. 2016 Mar;108(3). Epub 2015-12-01.

    PubMed abstract

    A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk

    Author(s): Travis RC; Appleby PN; Martin RM; Holly JM; Albanes D; Black A; Bueno-de-Mesquita HB; Chan JM; Chen C; Chirlaque MD; Cook MB; Deschasaux M; Donovan JL; Ferrucci L; Galan P; Giles GG; Giovannucci EL; Gunter MJ; Habel LA; Hamdy FC; Helzlsouer KJ; Hercberg S; Hoover RN; Janssen JA; Kaaks R; Kubo T; Le Marchand L; Metter EJ; Mikami K; Morris JK; Neal DE; Neuhouser ML; Ozasa K; Palli D; Platz EA; Pollak MN; Price AJ; Roobol M; Schaefer C; Schenk JM; Severi G; Stampfer MJ; Stattin P; Tamakoshi A; Tangen CM; Touvier M; Wald NJ; Weiss NS; Zeigler RG; Key TJ; Allen NE

    Cancer Res. 2016 Feb 26.

    PubMed abstract

    Characteristics of second breast events among women treated with breast-conserving surgery for DCIS in the community

    Author(s): Hassett MJ; Jiang W; Habel LA; Nekhlyudov L; Achacoso N; Acton L; Schnitt SJ; Schrag D; Punglia RS

    Breast Cancer Res Treat. 2016 Feb;155(3):541-9. Epub 2016-02-03.

    PubMed abstract

    Pioglitazone Use and Risk of Bladder Cancer--Reply

    Author(s): Ferrara A; Lewis JD; Habel LA

    JAMA. 2015 Dec 15;314(23):2568-9.

    PubMed abstract

    Analyzing historical trends in breast cancer biomarker expression: a feasibility study (1947-2009)

    Author(s): Krieger N; Habel LA; Waterman PD; Shabani M; Ellison-Loschmann L; Achacoso NS; Acton L; Schnitt SJ

    NPJ Breast Cancer. 2015;1. Epub 2015-10-7.

    PubMed abstract

    Physical Activity and Risk of Male Breast Cancer

    Author(s): Arem H; Brinton LA; Moore SC; Gapstur SM; Habel LA; Johnson K; Kolonel LN; McCormack VA; Michels KB; Sesso HD; Ursin G; Van Den Eeden SK; Weiderpass E; Cook MB; Matthews CE

    Cancer Epidemiol Biomarkers Prev. 2015 Sep 24.

    PubMed abstract

    Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes

    Author(s): Lewis JD; Habel LA; Quesenberry CP; Strom BL; Peng T; Hedderson MM; Ehrlich SF; Mamtani R; Bilker W; Vaughn DJ; Nessel L; Van Den Eeden SK; Ferrara A

    JAMA. 2015 Jul 21;314(3):265-77.

    PubMed abstract

    Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk

    Author(s): Brinton LA; Key TJ; Kolonel LN; Michels KB; Sesso HD; Ursin G; Van Den Eeden SK; Wood SN; Falk RT; Parisi D; Guillemette C; Caron P; Turcotte V; Habel LA; Isaacs CJ; Riboli E; Weiderpass E; Cook MB

    J Clin Oncol. 2015 Jun 20;33(18):2041-50. Epub 2015-05-11.

    PubMed abstract

    Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study

    Author(s): Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW

    Ann Surg Oncol. 2015 Jun 10.

    PubMed abstract

    A large multi-ethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences

    Author(s): Hoffmann TJ; Van Den Eeden SK; Sakoda LC; Jorgenson E; Habel LA; Graff RE; Passarelli MN; Cario CL; Emami NC; Chao CR; Ghai NR; Shan J; Ranatunga DK; Quesenberry CP; Aaronson D; Presti J; Zhaoming W; Berndt SI; Chanock SJ; McDonnell SK; French AJ; Schaid DJ; Thibodeau SN; Li Q; Freedman ML; Penney KL; Mucci LA; Haiman CA; Henderson BE; Seminara D; Kvale MN; Kwok PY; Schaefer C; Risch N; Witte JS

    Cancer Discov. 2015 Jun 1.

    PubMed abstract

    Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System

    Author(s): Keegan TH; Kurian AW; Gali K; Tao L; Lichtensztajn DY; Hershman DL; Habel LA; Caan BJ; Gomez SL

    Am J Public Health. 2015 May;105(5):938-46. Epub 2015-03-19.

    PubMed abstract

    Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression

    Author(s): Kwan ML; Kroenke CH; Sweeney C; Bernard PS; Weltzien EK; Castillo A; Factor RE; Maxfield KS; Stijleman IJ; Kushi LH; Quesenberry CP; Habel LA; Caan BJ

    BMC Cancer. 2015;15:278. Epub 2015-04-14.

    PubMed abstract

    A hybrid approach to identify subsequent breast cancer using pathology and automated health information data

    Author(s): Haque R; Shi J; Schottinger JE; Ahmed SA; Chung J; Avila C; Lee VS; Cheetham TC; Habel LA; Fletcher SW; Kwan ML

    Med Care. 2015 Apr;53(4):380-5.

    PubMed abstract

    Metformin use and lung cancer risk in patients with diabetes

    Author(s): Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA

    Cancer Prev Res (Phila). 2015 Feb;8(2):174-9.

    PubMed abstract

    Association between high-sensitivity C-reactive protein (hsCRP) and change in mammographic density over time in the SWAN mammographic density subcohort

    Author(s): Makboon K; Gold EB; Harvey DJ; Butler LM; Habel LA

    Cancer Causes Control. 2015 Jan 21.

    PubMed abstract

    Reply to L. Cabel et al

    Author(s): Fehrenbacher L; Capra A; Habel L

    J Clin Oncol. 2015 Jan 20;33(3):292-3. Epub 2014-12-15.

    PubMed abstract

    Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans

    Author(s): Feigelson HS; Carroll NM; Weinmann S; Haque R; Yu CL; Butler MG; Waitzfelder B; Wrenn MG; Capra A; McGlynn EA; Habel LA

    Springerplus. 2015;4:24. Epub 2015-01-17.

    PubMed abstract

    Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a Large Population-Based Cohort

    Author(s): Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS

    PLoS Genet. 2015 Jan;11(1):e1004930. Epub 2015-01-28.

    PubMed abstract

    Characterization and Treatment of Local Recurrence Following Breast Conservation for Ductal Carcinoma In Situ

    Author(s): Greenberg CC; Habel LA; Hughes ME; Nekhlyudov L; Achacoso N; Acton L; Schrag D; Jiang W; Edge S; Weeks JC; Punglia RS

    Ann Surg Oncol. 2014 Nov;21(12):3766-73. Epub 2014-05-24.

    PubMed abstract

    Distant Invasive Breast Cancer Recurrence Risk in Human Epidermal Growth Factor Receptor 2-Positive T1a and T1b Node-Negative Localized Breast Cancer Diagnosed From 2000 to 2006: A Cohort From an Integrated Health Care Delivery System

    Author(s): Fehrenbacher L; Capra AM; Quesenberry CP; Fulton R; Shiraz P; Habel LA

    J Clin Oncol. 2014 Jul 10;32(20):2151-8. Epub 2014-06-02.

    PubMed abstract

    Complications of herpes zoster in cancer patients

    Author(s): Tran TN; Ray GT; Horberg MA; Yawn BP; Castillo AL; Saddier P; Habel LA

    Scand J Infect Dis. 2014 Jul;46(7):528-32. Epub 2014-05-05.

    PubMed abstract

    Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer

    Author(s): Lewis JD; Habel L; Quesenberry C; Mamtani R; Peng T; Bilker WB; Hedderson M; Nessel L; Vaughn DJ; Strom BL; Ferrara A

    Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):636-45. Epub 2014-04-25.

    PubMed abstract

    Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer

    Author(s): Allen LA; Yood MU; Wagner EH; Aiello Bowles EJ; Pardee R; Wellman R; Habel L; Nekhlyudov L; Davis RL; Onitilo AA; Magid DJ; Pharmacovigilance Research Group

    Med Care. 2014 May;52(5):e30-8.

    PubMed abstract

    Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort; Prognostication of short and long term outcomes

    Author(s): Caan BJ; Sweeney C; Habel LA; Kwan ML; Kroenke CH; Weltzien EK; Quesenberry CP; Castillo A; Factor RE; Kushi LH; Bernard PS

    Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):725-34. Epub 2014-02-12.

    PubMed abstract

    Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort; Differences by age, race, and tumor characteristics

    Author(s): Sweeney C; Bernard PS; Factor RE; Kwan ML; Habel LA; Quesenberry CP; Shakespear K; Weltzien EK; Stijleman IJ; Davis CA; Ebbert MT; Castillo A; Kushi LH; Caan BJ

    Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):714-24. Epub 2014-02-12.

    PubMed abstract

    Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression

    Author(s): Kroenke CH; Sweeney C; Kwan ML; Quesenberry CP; Weltzien EK; Habel LA; Castillo A; Bernard PS; Factor RE; Kushi LH; Caan BJ

    Breast Cancer Res Treat. 2014 Apr;144(3):689-99. Epub 2014-03-07.

    PubMed abstract

    Antidepressants and testicular cancer

    Author(s): Friedman GD; Schwalbe J; Achacoso N; Meng MV; Kroenke CH; Habel LA

    Cancer Causes Control. 2014 Feb;25(2):251-8. Epub 2013-11-26.

    PubMed abstract

    Ovarian cancer rates after hysterectomy with and without salpingo-oophorectomy

    Author(s): Chan JK; Urban R; Capra AM; Jacoby V; Osann K; Whittemore A; Habel LA

    Obstet Gynecol. 2014 Jan;123(1):65-72.

    PubMed abstract

    Cohort Study of Insulin Glargine and Risk of Breast, Prostate, and Colorectal Cancer Among Patients With Diabetes

    Author(s): Habel LA; Danforth KN; Quesenberry CP; Capra A; Van Den Eeden SK; Weiss NS; Ferrara A

    Diabetes Care. 2013 Dec;36(12):3953-60. Epub 2013-10-29.

    PubMed abstract

    Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ

    Author(s): Collins LC; Achacoso N; Haque R; Nekhlyudov L; Fletcher SW; Quesenberry CP; Schnitt SJ; Habel LA

    Breast Cancer Res Treat. 2013 Jun;139(2):453-60.

    PubMed abstract

    HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease

    Author(s): Habel LA; Sakoda LC; Achacoso N; Ma XJ; Erlander MG; Sgroi DC; Fehrenbacher L; Greenberg D; Quesenberry CP

    Breast Cancer Res. 2013;15(2):R24. Epub 2013-03-14.

    PubMed abstract

    Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the Women's Health Initiative

    Author(s): Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD

    Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):365-73. Epub 2012 Dec 28.

    PubMed abstract

    Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007

    Author(s): Kurian AW; Lichtensztajn DY; Keegan TH; Leung RW; Shema SJ; Hershman DL; Kushi LH; Habel LA; Kolevska T; Caan BJ; Gomez SL

    Breast Cancer Res Treat. 2013 Jan;137(1):247-60. Epub 2012 Nov 9.

    PubMed abstract

    The Epidemiology of Herpes Zoster in Patients with Newly Diagnosed Cancer

    Author(s): Habel LA; Ray GT; Silverberg MJ; Horberg MA; Yawn BP; Castillo AL; Quesenberry CP Jr; Li Y; Sadier P; Tran TN

    Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):82-90. Epub 2012 Nov 1.

    PubMed abstract

    Smoking and survival after breast cancer diagnosis; a prospective observational study and systematic review

    Author(s): Braithwaite D; Izano M; Moore DH; Kwan ML; Tammemagi MC; Hiatt RA; Kerlikowske K; Kroenke CH; Sweeney C; Habel L; Castillo A; Weltzien E; Caan B

    Breast Cancer Res Treat. 2012 Nov;136(2):521-33. Epub 2012 Sep 29.

    PubMed abstract

    Utilization of HER2 genetic testing in a multi-institutional observational study

    Author(s): Goddard KA; Bowles EJ; Feigelson HS; Habel LA; Alford SH; McCarty CA; Nekhlyudov L; Onitilo AA; Rahm AK; Webster JA

    Am J Manag Care. 2012 Nov;18(11):704-12.

    PubMed abstract

    Antihypertensive Drugs and Lip Cancer in Non-Hispanic Whites

    Author(s): Friedman GD; Asgari MM; Warton EM; Chan J; Habel LA

    Arch Intern Med. 2012 Sep 10;172(16):1246-51.

    PubMed abstract

    Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study

    Author(s): Bowles EJ; Wellman R; Feigelson HS; Onitilo AA; Freedman AN; Delate T; Allen LA; Nekhlyudov L; Goddard KA; Davis RL; Habel LA; Yood MU; McCarty C; Magid DJ; Wagner EH; Pharmacovigilance Study Team

    J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305.

    PubMed abstract

    Patterns of Adjuvant Hormonal Therapy Use in the Northern California Breast Cancer Family Registry

    Author(s): Livaudais JC; Li C; John EM; Terry MB; Daly M; Buys SS; Habel L; Thompson B; Yanez ND; Coronado GD

    J Womens Health (Larchmt). 2012 Sep;21(9):950-8. Epub 2012 Jun 25.

    PubMed abstract

    Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS

    Author(s): Nekhlyudov L; Habel LA; Achacoso N; Jung I; Haque R; Collins LC; Schnitt SJ; Quesenberry CP Jr; Fletcher SW

    J Natl Cancer Inst. 2012 Apr 18;104(8):614-21. Epub 2012 Apr 5.

    PubMed abstract

    Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure

    Author(s): Delate T; Aiello Bowles EJ; Pardee R; Wellman RD; Habel LA; Ulcickas Yood M; Nekhlyudov L; Goddard KA; Davis RL; McCarty CA; Onitilo AA; Spencer Feigelson H; Freml J; Wagner E

    Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):673-80. Epub 2012 Feb 15.

    PubMed abstract

    A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

    Author(s): Kratz JR; He J; Van Den Eeden SK; Zhu ZH; Gao W; Pham PT; Mulvihill MS; Ziaei F; Zhang H; Su B; Zhi X; Quesenberry CP; Habel LA; Deng Q; Wang Z; Zhou J; Li H; Huang MC; Yeh CC; Segal MR; Ray MR; Jones KD; Raz DJ; Xu Z; Jahan TM; Berryman D; He B; Mann MJ; Jablons DM

    Lancet. 2012 Mar 3;379(9818):823-32. Epub 2012 Jan 27.

    PubMed abstract

    Risk of cancer in patients exposed to gabapentin in two electronic medical record systems

    Author(s): Irizarry MC; Webb DJ; Boudiaf N; Logie J; Habel LA; Udaltsova N; Friedman GD

    Pharmacoepidemiol Drug Saf. 2012 Feb;21(2):214-25. Epub 2011 Dec 6.

    PubMed abstract

    Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

    Author(s): Livaudais JC; Hershman DL; Habel L; Kushi L; Gomez SL; Li CI; Neugut AI; Fehrenbacher L; Thompson B; Coronado GD

    Breast Cancer Res Treat. 2012 Jan;131(2):607-17. Epub 2011 Sep 16.

    PubMed abstract

    ADHD medications and risk of serious cardiovascular events in young and middle-aged adults

    Author(s): Habel LA; Cooper WO; Sox CM; Chan KA; Fireman BH; Arbogast PG; Cheetham TC; Quinn VP; Dublin S; Boudreau DM; Andrade SE; Pawloski PA; Raebel MA; Smith DH; Achacoso N; Uratsu C; Go AS; Sidney S; Nguyen-Huynh MN; Ray WA; Selby JV

    JAMA. 2011 Dec 28;306(24):2673-83. Epub 2011 Dec 12.

    PubMed abstract

    ADHD drugs and serious cardiovascular events in children and young adults

    Author(s): Cooper WO; Habel LA; Sox CM; Chan KA; Arbogast PG; Cheetham TC; Murray KT; Quinn VP; Stein CM; Callahan ST; Fireman BH; Fish FA; Kirshner HS; O'Duffy A; Connell FA; Ray WA

    N Engl J Med. 2011 Nov 17;365(20):1896-904. Epub 2011 Nov 1.

    PubMed abstract

    Re: a case-control study of levothyroxine and the risk of colorectal cancer

    Author(s): Friedman GD; Schwalbe JS; Habel LA

    J Natl Cancer Inst. 2011 Nov 2;103(21):1637-9. Epub 2011 Oct 18.

    PubMed abstract

    Multivitamin use and breast cancer outcomes in women with early-stage breast cancer; the Life After Cancer Epidemiology study

    Author(s): Kwan ML; Greenlee H; Lee VS; Castillo A; Gunderson EP; Habel LA; Kushi LH; Sweeney C; Tam EK; Caan BJ

    Breast Cancer Res Treat. 2011 Nov;130(1):195-205. Epub 2011 May 11.

    PubMed abstract

    Reproductive and menstrual factors and risk of ductal carcinoma in situ of the breast in a cohort of postmenopausal women

    Author(s): Kabat GC; Kim MY; Woods NF; Habel LA; Messina CR; Wactawski-Wende J; Stefanick ML; Chlebowski RT; Wassertheil-Smoller S; Rohan TE

    Cancer Causes Control. 2011 Oct;22(10):1415-24. Epub 2011 Jul 13.

    PubMed abstract

    Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort

    Author(s): Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW

    Breast Cancer Res Treat. 2011 Sep;129(2):549-56. Epub 2011 Apr 11.

    PubMed abstract

    Cohort study of pioglitazone and cancer incidence in patients with diabetes

    Author(s): Ferrara A; Lewis JD; Quesenberry CP Jr; Peng T; Strom BL; Van den Eeden SK; Ehrlich SF; Habel LA

    Diabetes Care. 2011 Apr;34(4):923-9.

    PubMed abstract

    A method to estimate off-schedule observations in a longitudinal study

    Author(s): Reeves KW; Stone RA; Modugno F; Ness RB; Vogel VG; Weissfeld JL; Habel LA; Vuga M; Cauley JA

    Ann Epidemiol. 2011 Apr;21(4):297-303.

    PubMed abstract

    Norepinephrine antagonists and cancer risk

    Author(s): Friedman GD; Udaltsova N; Habel LA

    Int J Cancer. 2011 Feb 1;128(3):737-8; author reply 739.

    PubMed abstract

    Serial glycosylated hemoglobin levels and risk of colorectal neoplasia among patients with type 2 diabetes mellitus

    Author(s): Yang YX; Habel LA; Capra AM; Achacoso NS; Ferrara A; Levin TR; Lewis JD; Quesenberry CP Jr

    Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3027-36. Epub 2010 Oct 11.

    PubMed abstract

    Metabolic syndrome and mammographic density: The study of women's health across the nation (SWAN)

    Author(s): Conroy SM; Butler LM; Harvey D; Gold EB; Sternfeld B; Greendale GA; Habel LA

    Int J Cancer. 2010 Nov 23.

    PubMed abstract

    Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories

    Author(s): Baehner FL; Achacoso N; Maddala T; Shak S; Quesenberry CP Jr; Goldstein LC; Gown AM; Habel LA

    J Clin Oncol. 2010 Oct 1;28(28):4300-6. Epub 2010 Aug 9.

    PubMed abstract

    Lipophilic statin use and risk of breast cancer subtypes

    Author(s): Woditschka S; Habel LA; Udaltsova N; Friedman GD; Sieh W

    Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2479-87. Epub 2010 Aug 20.

    PubMed abstract

    Diabetes and cancer: a consensus report

    Author(s): Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D

    CA Cancer J Clin. 2010 Jul-Aug;60(4):207-21. Epub 2010 Jun 16.

    PubMed abstract

    Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans

    Author(s): Haque R; Achacoso NS; Fletcher SW; Nekhlyudov L; Collins LC; Schnitt SJ; Quesenberry CP Jr; Habel LA

    Am J Manag Care. 2010 May;16(5):351-60.

    PubMed abstract

    Active, but not passive cigarette smoking was inversely associated with mammographic density

    Author(s): Butler LM; Gold EB; Conroy SM; Crandall CJ; Greendale GA; Oestreicher N; Quesenberry CP Jr; Habel LA

    Cancer Causes Control. 2010 Feb;21(2):301-11.

    PubMed abstract

    Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened

    Author(s): Friedman GD; Udaltsova N; Chan J; Quesenberry CP Jr; Habel LA

    Cancer Causes Control. 2009 Dec;20(10):1821-35.

    PubMed abstract

    Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients

    Author(s): Collins LC; Achacoso N; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP Jr; Puligandla B; Alshak NS; Goldstein LC; Gown AM; Schnitt SJ; Habel LA

    Am J Surg Pathol. 2009 Dec;33(12):1802-8.

    PubMed abstract

    Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting

    Author(s): Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP Jr

    Breast Cancer Res. 2009;11(6):R85. Epub 2009 Nov 18.

    PubMed abstract

    Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity

    Author(s): Friedman GD; Jiang SF; Udaltsova N; Quesenberry CP Jr; Chan J; Habel LA

    Int J Cancer. 2009 Nov 1;125(9):2173-8.

    PubMed abstract

    Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study

    Author(s): Flick ED; Habel LA; Chan KA; Haque R; Quinn VP; Van Den Eeden SK; Sternfeld B; Orav EJ; Seeger JD; Quesenberry CP Jr; Caan BJ

    Drugs. 2009 Jul 30;69(11):1445-57.

    PubMed abstract

    Pharmaceuticals that cause mammary gland tumors in animals: findings in women

    Author(s): Friedman GD; Jiang SF; Udaltsova N; Chan J; Quesenberry CP Jr; Habel LA

    Breast Cancer Res Treat. 2009 Jul;116(1):187-94. Epub 2008 Jul 16.

    PubMed abstract

    Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery

    Author(s): Nekhlyudov L; Habel LA; Achacoso NS; Jung I; Haque R; Collins LC; Schnitt SJ; Quesenberry CP Jr; Fletcher SW

    J Clin Oncol. 2009 Jul 1;27(19):3211-6. Epub 2009 May 11.

    PubMed abstract

    Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation

    Author(s): Reeves KW; Stone RA; Modugno F; Ness RB; Vogel VG; Weissfeld JL; Habel LA; Sternfeld B; Cauley JA

    Int J Cancer. 2009 Mar 1;124(5):1169-77.

    PubMed abstract

    Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006

    Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P

    Gut. 2009 Feb;58(2):182-8. Epub 2008 Oct 31.

    PubMed abstract

    Mothers of children diagnosed with attention-deficit/hyperactivity disorder: health conditions and medical care utilization in periods before and after birth of the child

    Author(s): Ray GT; Croen LA; Habel LA

    Med Care. 2009 Jan;47(1):105-14.

    PubMed abstract

    Thiazolidinedione therapy is not associated with increased colonic neoplasia risk in patients with diabetes mellitus

    Author(s): Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP Jr; Habel LA

    Gastroenterology. 2008 Dec;135(6):1914-23, 1923.e1. Epub 2008 Sep 13.

    PubMed abstract

    Hemochromatosis gene status as a risk factor for Barrett's esophagus

    Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore GJ; Quesenberry C; Buffler P

    Dig Dis Sci. 2008 Dec;53(12):3095-102. Epub 2008 May 10.

    PubMed abstract

    Menstrual and reproductive factors in relation to mammographic density: the Study of Women's Health Across the Nation (SWAN)

    Author(s): Butler LM; Gold EB; Greendale GA; Crandall CJ; Modugno F; Oestreicher N; Quesenberry CP Jr; Habel LA

    Breast Cancer Res Treat. 2008 Nov;112(1):165-74. Epub 2007 Dec 9.

    PubMed abstract

    Helicobacter pylori and gastroesophageal reflux disease: a case-control study

    Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Rumore G; Quesenberry C; Buffler P; Parsonnet J

    Helicobacter. 2008 Oct;13(5):352-60.

    PubMed abstract

    Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study

    Author(s): Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Rumore G; Quesenberry C; Buffler P; Parsonnet J

    Gut. 2008 Jun;57(6):727-33. Epub 2007 Sep 25.

    PubMed abstract

    Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors

    Author(s): Kwan ML; Habel LA; Flick ED; Quesenberry CP; Caan B

    Breast Cancer Res Treat. 2008 Jun;109(3):573-9. Epub 2007 Aug 3.

    PubMed abstract

    Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

    Author(s): Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L

    J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. Epub 2008 Apr 8.

    PubMed abstract

    Glycemic status and risk of prostate cancer

    Author(s): Darbinian JA; Ferrara AM; Van Den Eeden SK; Quesenberry CP Jr; Fireman B; Habel LA

    Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):628-35.

    PubMed abstract

    Physical activity and mammographic density in a cohort of midlife women

    Author(s): Oestreicher N; Capra A; Bromberger J; Butler LM; Crandall CJ; Gold EB; Greendale GA; Modugno F; Sternfeld B; Habel LA

    Med Sci Sports Exerc. 2008 Mar;40(3):451-6.

    PubMed abstract

    Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients

    Author(s): Friedman GD; Flick ED; Udaltsova N; Chan J; Quesenberry CP Jr; Habel LA

    Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):27-36.

    PubMed abstract

    Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses

    Author(s): Oestreicher N; Friedman GD; Jiang SF; Chan J; Quesenberry C Jr; Habel LA

    Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1268-72.

    PubMed abstract

    Medical therapy for diabetes is associated with increased use of lower endoscopy

    Author(s): Lewis JD; Capra AM; Achacoso NS; Ferrara A; Levin TR; Quesenberry CP Jr; Habel LA

    Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1195-202.

    PubMed abstract

    Statin use and risk of prostate cancer in the California Men's Health Study cohort

    Author(s): Flick ED; Habel LA; Chan KA; Van Den Eeden SK; Quinn VP; Haque R; Orav EJ; Seeger JD; Sadler MC; Quesenberry CP Jr; Sternfeld B; Jacobsen SJ; Whitmer RA; Caan BJ

    Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2218-25. Epub 2007 Oct 30.

    PubMed abstract

    Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients

    Author(s): Collins LC; Achacoso NA; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP Jr; Alshak NS; Puligandla B; Brodsky GL; Schnitt SJ; Habel LA

    Mod Pathol. 2007 Nov;20(11):1149-55. Epub 2007 Aug 31.

    PubMed abstract

    Mammographic density in a multiethnic cohort

    Author(s): Habel LA; Capra AM; Oestreicher N; Greendale GA; Cauley JA; Bromberger J; Crandall CJ; Gold EB; Modugno F; Salane M; Quesenberry C; Sternfeld B

    Menopause. 2007 Sep-Oct;14(5):891-9.

    PubMed abstract

    NSAIDs and breast cancer recurrence in a prospective cohort study

    Author(s): Kwan ML; Habel LA; Slattery ML; Caan B

    Cancer Causes Control. 2007 Aug;18(6):613-20. Epub 2007 Apr 3.

    PubMed abstract

    The association between mammographic breast density and bone mineral density in the study of women's health across the nation

    Author(s): Crandall CJ; Zheng Y; Karlamangla A; Sternfeld B; Habel LA; Oestreicher N; Johnston J; Cauley JA; Greendale GA

    Ann Epidemiol. 2007 Aug;17(8):575-83. Epub 2007 May 29.

    PubMed abstract

    Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan

    Author(s): Haque R; Quinn VP; Habel LA; Enger SM; Sternfeld B; Van Den Eeden SK; Sadler M; Chiu V; Caan B

    Cancer. 2007 Jul 15;110(2):275-81.

    PubMed abstract

    Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women

    Author(s): Friedman GD; Oestreicher N; Chan J; Quesenberry CP Jr; Udaltsova N; Habel LA

    Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2102-6.

    PubMed abstract

    Attention-deficit/hyperactivity disorder in children: excess costs before and after initial diagnosis and treatment cost differences by ethnicity

    Author(s): Ray GT; Levine P; Croen LA; Bokhari FA; Hu TW; Habel LA

    Arch Pediatr Adolesc Med. 2006 Oct;160(10):1063-9.

    PubMed abstract

    Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer

    Author(s): Caan BJ; Emond JA; Natarajan L; Castillo A; Gunderson EP; Habel L; Jones L; Newman VA; Rock CL; Slattery ML; Stefanick ML; Sternfeld B; Thomson CA; Pierce JP

    Breast Cancer Res Treat. 2006 Sep;99(1):47-57. Epub 2006 Mar 16.

    PubMed abstract

    California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting

    Author(s): Enger SM; Van Den Eeden SK; Sternfeld B; Loo RK; Quesenberry CP Jr; Rowell S; Sadler MC; Schaffer DM; Habel LA; Caan BJ

    BMC Public Health. 2006 Jun 30;6:172.

    PubMed abstract

    A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients

    Author(s): Habel LA; Shak S; Jacobs MK; Capra A; Alexander C; Pho M; Baker J; Walker M; Watson D; Hackett J; Blick NT; Greenberg D; Fehrenbacher L; Langholz B; Quesenberry CP

    Breast Cancer Res. 2006;8(3):R25. Epub 2006 May 31.

    PubMed abstract

    Barrett's esophagus and medications that relax the lower esophageal sphincter

    Author(s): Corley DA; Levin TR; Habel LA; Buffler PA

    Am J Gastroenterol. 2006 May;101(5):937-44.

    PubMed abstract

    Use of raloxifene among women with a history of breast cancer

    Author(s): Habel LA; Pressman A; Ettinger B; Sidney S; Suh-Burgmann B; Fehrenbacher L; Quesenberry CP

    Breast Cancer Res Treat. 2006 Mar;96(2):123-9.

    PubMed abstract

    Treatment with stimulants among youths in a large California health plan

    Author(s): Habel LA; Schaefer CA; Levine P; Bhat AK; Elliott G

    J Child Adolesc Psychopharmacol. 2005 Feb;15(1):62-7.

    PubMed abstract

    Mammographic density and breast cancer after ductal carcinoma in situ

    Author(s): Habel LA; Dignam JJ; Land SR; Salane M; Capra AM; Julian TB

    J Natl Cancer Inst. 2004 Oct 6;96(19):1467-72.

    PubMed abstract

    Risk of subsequent cancer following invasive or in situ squamous cell skin cancer

    Author(s): Efird JT; Friedman GD; Habel L; Tekawa IS; Nelson LM

    Ann Epidemiol. 2002 Oct;12(7):469-75.

    PubMed abstract

    Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US

    Author(s): Habel LA; Zhao W; Stanford JL

    Cancer Causes Control. 2002 Jun;13(5):427-34.

    PubMed abstract

    CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma

    Author(s): Shibata A; Parsonnet J; Longacre TA; Garcia MI; Puligandla B; Davis RE; Vogelman JH; Orentreich N; Habel LA

    Carcinogenesis. 2002 Mar;23(3):419-24.

    PubMed abstract

    Surveillance and survival in Barrett's adenocarcinomas: a population-based study

    Author(s): Corley DA; Levin TR; Habel LA; Weiss NS; Buffler PA

    Gastroenterology. 2002 Mar;122(3):633-40.

    PubMed abstract

    Histological classification of gastric adenocarcinoma for epidemiological research: concordance between pathologists

    Author(s): Shibata A; Longacre TA; Puligandla B; Parsonnet J; Habel LA

    Cancer Epidemiol Biomarkers Prev. 2001 Jan;10(1):75-8.

    PubMed abstract

    Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort

    Author(s): Habel LA; Van Den Eeden SK; Friedman GD

    Prostate. 2000 May 1;43(2):136-43.

    PubMed abstract

    Cimetidine use and risk of breast, prostate, and other cancers

    Author(s): Habel LA; Levin TR; Friedman GD

    Pharmacoepidemiol Drug Saf. 2000 Mar;9(2):149-55.

    PubMed abstract

    Epidemiology of ductal carcinoma in situ

    Author(s): Habel LA

    Semin Breast Dis. 2000;3:187-99.

    PubMed abstract

    Barbiturates and lung cancer: a re-evaluation

    Author(s): Friedman GD; Habel LA

    Int J Epidemiol. 1999 Jun;28(3):375-9.

    PubMed abstract

    Barbiturates, smoking, and bladder cancer risk

    Author(s): Habel LA; Bull SA; Friedman GD

    Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1049-50.

    PubMed abstract